Multiplex Assays Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 | The Business Research Company

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Multiplex Assays Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $5.7 billion In 2028 At A CAGR Of 9.5% :

The multiplex assays market size has grown strongly in recent years. It will grow from $3.61 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances and a rapid growth in aging population.

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

Multiplex Assays Market Major Segments
The multiplex assays market covered in this report is segmented -
1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
4) By Application: Research And Development, Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Key Driver - Rising Incidence Of Chronic Diseases Propels Growth In The Global Multiplex Assay Market

An increased incidence of chronic diseases is driving the growth of the global multiplex assay market. Multiplex assay is extensively used in clinical trials to analyze and study the efficacy of a disease and for the detection of antibodies against those diseases. According to the World Health Organization (WHO) report published in April 2021, chronic diseases, also known as non-communicable diseases (NCDs), kill 41 million people each year, equivalent to 71% of all deaths globally. Every year, between the ages of 30 and 69 years, more than 15 million people die from an NCD. Due to the growing acceptance and the advantages of multiplex assays over traditional assays, such as quicker analysis, the market for multiplex assays is expected to develop rapidly, driving growth in the forecast period.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=5775&type=smp

Prominent Trend - Quantumdx Group Introduces Cutting-Edge Multiplex Respiratory Panel Test To Reinforce Market Presence

Companies in the market are launching innovative tests based on multiplex assays to strengthen their position in the market. For instance, in May 2022, QuantuMDx Group Limited, a UK-based developer of transformational point-of-care diagnostics, launched its new respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. The Q-POCTM SARS (severe acute respiratory syndrome)-CoV-2, Flu A/B, and RSV Assay is a multiplex panel that can detect SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) at the point of need.

Multiplex Assays Market Players
Major companies operating in the multiplex assays market report are Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Qiagen NV, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Dexcom Inc., Medtronic Inc., Senseonics Holdings Inc., Adavium Medical, DK Diagnostics, Crosmed, Ortopedia Alemana, Simed, Ab Enzymes Gmbh, Bluestar Adisseo Co., BASF SE, Chr. Hansen Holding, Novozymes, BiotechAfrica, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the multiplex assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Multiplex Assays Market Report Structure
3. Multiplex Assays Market Trends And Strategies
4. Multiplex Assays Market - Macro Economic Scenario
5. Multiplex Assays Market Size And Growth
…..
27. Multiplex Assays Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.